Why is Transgene Biotek falling/rising?

As of 11-Sep, Transgene Biotek Ltd is currently priced at 3.78, reflecting a decrease of 0.04 or 1.05%. The stock has underperformed its sector by 0.27% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 89.23% compared to the 5-day average. Over the past week, the stock has decreased by 5.74%, and it has experienced a substantial decline of 21.58% over the past month, contributing to a year-to-date drop of 44.66%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the Sensex has shown a positive return of 1.03% over the past week and 1.17% over the past month, contrasting sharply with Transgene Biotek's negative performance. This underperformance relative to the benchmark indicates that the stock is not only struggling in the short term but also lagging significantly behind the overall market trends. The stark difference in performance highlights the challenges faced by Transgene Biotek in attracting investor interest and maintaining liquidity, which further exacerbates its declining stock price.